Opiant Pharmaceuticals, Inc.
(NASDAQ : OPNT)

( )
OPNT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.12%196.411.2%$567.51m
TSROTESARO, Inc.
0.08%74.3114.4%$551.02m
CELGCelgene Corporation
2.03%70.901.2%$541.17m
GILDGilead Sciences, Inc.
0.62%68.140.9%$521.04m
BIIBBiogen Inc.
0.88%322.611.3%$364.53m
ILMNIllumina, Inc.
2.44%336.923.5%$356.07m
REGNRegeneron Pharmaceuticals, Inc.
0.60%377.962.6%$267.70m
AAgilent Technologies, Inc.
0.99%71.751.5%$240.96m
VRTXVertex Pharmaceuticals Incorporated
1.28%175.451.9%$234.92m
ALXNAlexion Pharmaceuticals, Inc.
1.90%117.012.0%$146.65m
SRPTSarepta Therapeutics, Inc.
0.10%125.1315.4%$110.90m
INCYIncyte Corporation
3.16%67.672.5%$104.86m
EXASExact Sciences Corporation
3.27%71.7925.3%$97.81m
NKTRNektar Therapeutics
1.48%36.975.5%$91.00m
SGENSeattle Genetics, Inc.
1.66%61.956.6%$85.00m

Company Profile

Opiant Pharmaceuticals, Inc. is a biopharmaceutical company, which develops pharmaceutical solutions for common addictions and related disorders. The company focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Santa Monica, CA.